SBMFF:OTCMKTS
Sino Biopharmaceutical Ltd
0,76 $
0,00%
(0,00) 1 p
15. apr, 11:31:08 GMT −4 · USD
search
Kõik sümbolid
1 p
5 p
1 kuu
6 kuud
YTD
1 a
5 a
MAX
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse SBMFF põhistatistika genereerimine…
Turu kapit.
102,35 mld
Keskm. maht
171,00
Maht
0,00
52 näd kõrgeim
1,24 $
52 näd madalaim
0,49 $
Beeta
0,70
Käibivad aktsiad
18,75 mld
Töötajate arv
21 tuh
Uudised
Erinevatest veebiallikatest
TipRanks
·
1 päeva eest
Sino Biopharmaceutical Bolsters Leadership for Global Clinical Development
Profiil
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020.
The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
Teave üksuse Sino Biopharmaceutical Ltd kohta
AI genereeritud sisu võib sisaldada vigu. Lisateave